Intravenous infusion of n-3 polyunsaturated fatty acids and ventricular tackycardi in patients with implantable cardioverter defibrillator (ICD)

Department of Cardiology, Aalborg Hospital0 个研究点开始时间: 2007年7月30日最近更新: 2017年8月21日

试验速览

暂无简介。

•Patients with an implantable cardioverter defibrillator (ICD) implanted at least 3 months prior to inclusion.
•Sustained ventricular tackycardia was inducible during the primary electrophysiological testing prior to implantation of the ICD.
•History of successfull treatment of a ventricular tackycardia episode with anti-tackycardia pacing (ATP) either the primary electrophysiological testing or at a later time point
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range

•Allergy to fish or egg protein.
•Blood pressure > 160/90 (with or without treatment).
•Myocardial infarction or coronary revascularisation within the previous 6 months.
•HbA1c >10 %.
•Plasma-creatinine > 200 microM
•Plasma-alanineaminotransferase > 150 U/L
•INR > 3.5
•Plasma-potassium > 3.5 mM
•Fasting triglycerides > 3 mM
•Ongoing infection
•Other serious illlness
•Inability to informed consent

发起方

Department of Cardiology, Aalborg Hospital